We are live on !
Find out more
Aster Capital Management Portfolio holdings
AUM
$275M
Turnover
72.56%
1-Year Est. Return
18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
(-41%)
Cap. Flow
-$180M
Cap. Flow % of AUM
Cap. Flow %
-65.37%
Top 10 Holdings %
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$4.57M |
| 2 |
Ovintiv
OVV
|
+$3.99M |
| 3 |
Kimco Realty
KIM
|
+$3.52M |
| 4 |
Astera Labs
ALAB
|
+$3.33M |
| 5 |
Hut 8
HUT
|
+$2.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$11.3M |
| 2 |
Apple
AAPL
|
+$7.75M |
| 3 |
Microsoft
MSFT
|
+$6.82M |
| 4 |
Honeywell
HON
|
+$6.34M |
| 5 |
Coca-Cola
KO
|
+$5.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.08% |
| 2 | Technology | 15.72% |
| 3 | Industrials | 13.9% |
| 4 | Healthcare | 13.43% |
| 5 | Consumer Discretionary | 10.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
CrowdStrike
CRWD
$232B
| $449K | 0.16% |
+1,695
| New | +$360K |
2026 Q3
0 quarters
|
|
202
Ally Financial
ALLY
$11.5B
| $447K | 0.16% |
+11,887
| New | +$511K |
2026 Q3
0 quarters
|
|
203
Guardant Health
GH
$20.5B
| $446K | 0.16% |
2,501
-6,848
| -73% | -$1.12M |
2026 Q2
1 quarter
|
|
204
Chubb
CB
$144B
| $444K | 0.16% |
1,365
-3,482
| -72% | -$1.2M |
2026 Q2
1 quarter
|
|
205
Flex
FLEX
$27.7B
| $438K | 0.16% |
3,985
-5,413
| -58% | -$641K |
2026 Q2
1 quarter
|
|
206
Accelevation Holdings Corp. Class A Ordinary Shares
ACCV
$1.55B
| $435K | 0.16% |
+24,218
| New | +$435K |
2026 Q3
0 quarters
|
|
207
Deckers Outdoor
DECK
$11.6B
| $434K | 0.16% |
5,551
+1,494
| +37% | +$138K |
2025 Q3
4 quarters
|
|
208
Baker Hughes
BKR
$49.1B
| $432K | 0.16% |
7,861
-698
| -8% | -$41.6K |
2026 Q2
1 quarter
|
|
209
RLI Corp
RLI
$6.39B
| $429K | 0.16% |
+7,765
| New | +$479K |
2026 Q3
0 quarters
|
|
210
CoStar Group
CSGP
$12.5B
| $426K | 0.16% |
15,550
+3,558
| +30% | +$107K |
2026 Q2
1 quarter
|
|
211
Brookfield Renewable
BEPC
$5.7B
| $425K | 0.15% |
15,062
+13,109
| +671% | +$429K |
2026 Q2
1 quarter
|
|
212
Equinix
EQIX
$104B
| $425K | 0.15% |
+420
| New | +$437K |
2026 Q3
0 quarters
|
|
213
Occidental Petroleum
OXY
$58.7B
| $421K | 0.15% |
7,612
-219
| -3% | -$12.5K |
2026 Q2
1 quarter
|
|
214
KKR & Co
KKR
$87.5B
| $421K | 0.15% |
4,608
-2,750
| -37% | -$281K |
2026 Q2
1 quarter
|
|
215
Becton Dickinson
BDX
$59.4B
| $420K | 0.15% |
2,346
+1,619
| +223% | +$281K |
2025 Q4
3 quarters
|
|
216
Everus Construction Group
ECG
$4.35B
| $417K | 0.15% |
3,547
+1,777
| +100% | +$225K |
2025 Q4
3 quarters
|
|
217
Charles River Laboratories
CRL
$16.2B
| $415K | 0.15% |
+1,408
| New | +$371K |
2026 Q3
0 quarters
|
|
218
Virtu Financial
VIRT
$5.26B
| $414K | 0.15% |
+7,512
| New | +$450K |
2026 Q3
0 quarters
|
|
219
IDEX
IEX
$17.5B
| $413K | 0.15% |
+1,813
| New | +$413K |
2026 Q3
0 quarters
|
|
220
Bath & Body Works
BBWI
$4.31B
| $412K | 0.15% |
25,904
+23,398
| +934% | +$448K |
2025 Q3
4 quarters
|
|
221
HF Sinclair
DINO
$17.3B
| $412K | 0.15% |
3,838
-8,372
| -69% | -$792K |
2026 Q1
2 quarters
|
|
222
Constellation Brands
STZ
$24.6B
| $411K | 0.15% |
+3,636
| New | +$469K |
2026 Q3
0 quarters
|
|
223
Boston Scientific
BSX
$64.3B
| $410K | 0.15% |
9,395
-6,277
| -40% | -$291K |
2026 Q2
1 quarter
|
|
224
Aon
AON
$71.8B
| $409K | 0.15% |
1,478
-3,225
| -69% | -$1.09M |
2025 Q4
3 quarters
|
|
225
International Flavors & Fragrances
IFF
$20.3B
| $409K | 0.15% |
+4,894
| New | +$404K |
2026 Q3
0 quarters
|
|
Similar funds
SL
CP
MEPT
Aster Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.
Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.
- Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
- Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
- Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
- Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
- Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
- Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
- Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.